Pharmaust Limited (AU:PAA) has released an update.
PharmAust Limited has formally notified the ASX of the appointment of Dr. Kathryn MacFarlane as a director, effective from June 17, 2024. According to the initial director’s interest notice, Dr. MacFarlane does not currently hold any securities in the company. This regulatory disclosure, as required by the listing rules, ensures transparency of director’s interests upon their appointment.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
